Sign In
Buy CHE
$444.11
+8.04 (+1.84%)
At Close: Jun 23, 2026
Reasons to Retain Chemed Stock in Your Portfolio Now
11:25am, Tuesday, 08'th Oct 2024
Investors feel optimistic about CHE's strong growth prospects in the VITAS business. Yet, unfavorable macroeconomic conditions are concerning.
Final Trades: Exxon, Chemed, Las Vegas Sands and the IEO
01:23pm, Tuesday, 01'st Oct 2024
The Investment Committee give you their top stocks to watch for the second half.
AMED or CHE: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 30'th Sep 2024
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Amedisys (AMED) and Chemed (CHE). But which of these two stocks presents investors with the better valu
LEO Pharma Unveils Most Extensive EADV Program To Date with 5 Late Breaking Abstracts and 23 Posters Sharing Clinical and Real-World Data
04:00am, Wednesday, 25'th Sep 2024
BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma Unveils Most Extensive EADV Program To Date with 5 Late Breaking Abstracts and 23 Posters Sharing Clinical and Real-World Data.
Why Chemed (CHE) is a Top Growth Stock for the Long-Term
10:50am, Wednesday, 18'th Sep 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30
01:46pm, Friday, 13'th Sep 2024
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the third quarter ended September 30, 2024, on Tuesday, October 29, 2024, followi
Chemed (CHE) Up 5.7% Since Last Earnings Report: Can It Continue?
12:38pm, Friday, 23'rd Aug 2024
Chemed (CHE) reported earnings 30 days ago. What's next for the stock?
Chemed Remains A Buy On Long-Term Economics
11:23pm, Thursday, 15'th Aug 2024
Chemed continues to present with exceptional economic characteristics now at depressed valuations vs. history. The business is highly profitable and earns high rates of return on all the capital that'
Here's Why Chemed (CHE) is a Strong Growth Stock
10:47am, Thursday, 15'th Aug 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Ways to Play the Long-Term Care Crisis in 2024
11:17am, Thursday, 08'th Aug 2024
Morningstar.com published an interesting piece in July about the long-term health care crisis. It pointed out that Americans paid out $245 billion for long term care to paid caregivers, nursing homes
Trade Tracker: Karen Firestone buys Abbott Labs, Chemed, Costar Group and sells Home Depot
01:16pm, Wednesday, 07'th Aug 2024
Karen Firestone, chairman and CEO at Aureus Asset Management, joins CNBC's "Halftime Report" to detail her latest portfolio moves.
ADUS vs. CHE: Which Stock Is the Better Value Option?
12:40pm, Monday, 05'th Aug 2024
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Chemed (CHE). But which of these two companies is the best option for those l
Why Chemed (CHE) is a Top Growth Stock for the Long-Term
10:46am, Tuesday, 30'th Jul 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
3 Reasons Why Growth Investors Shouldn't Overlook Chemed (CHE)
01:45pm, Monday, 29'th Jul 2024
Chemed (CHE) possesses solid growth attributes, which could help it handily outperform the market.
Chemed (CHE) Q2 Earnings Miss Estimates, Margins Expand
09:51am, Thursday, 25'th Jul 2024
Chemed's (CHE) VITAS segment delivers impressive revenue growth and margin expansion in the second quarter of 2024.
